PREPrenetics Global LimitedHealthcare · Medical - Diagnostics & Researchas of 2026-09-16
Horizon

Issued 2026-09-16 at $22.02 · now $22.02 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, PRE has typically landed between $15.50 and $30.01 — a range of −29.6% to +36.3% from the issuance price $22.02.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,276 overlapping 1 month windows · 2021-07-192026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($22.02) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where PRE has typically landed a month from the 2026-09-16 close of $22.02 — the range is history, not a prediction.

$15.5worst · -29.6%$30.01best · +36.3%
  • now $22.02 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $21.7 (-1.5%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $19.46$23.93
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $15.5$30.01
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,276 windows spanning 2021-07-19 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2022-05-12−55.7%−55.7%+1.6%
2022-10-25−52.1%−52.1%+0.6%
2022-05-13−50.0%−56.4%+0.0%
3 best
2025-04-23+148.5%+0.0%+148.5%
2024-04-19+109.3%+0.0%+114.5%
2025-04-24+103.4%−1.4%+121.5%

1,276 overlapping windows · 2021-07-192026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
40%
−5.1%
n=5
Feb
0%
−9.6%
n=5
Mar
20%
−7.7%
n=5
Apr
60%
+6.4%
n=5
May
80%
+19.2%
n=5
Jun
20%
−8.0%
n=5
Jul
0%
−7.2%
n=5
Aug
17%
−2.1%
n=6
Sep
33%
+6.8%
n=6
Oct
40%
−5.7%
n=5
Nov
20%
−11.1%
n=5
Dec
80%
+17.5%
n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$26$72026-08-25: 1 insider purchase, $116K — Rosin Brian J2026-08-24: 3 insider purchases, $746K — Rosin Brian J, Yeung Danny Sheng Wu …2026-08-20: 1 insider purchase, $137K — Yeung Danny Sheng Wu2026-08: 5 open-market purchases, $1000K↑ buys↓ salesofficer Rosin Brian J — Purchase on 2026-08-25, filed 1 day after the tradeofficer Rosin Brian J — Purchase on 2026-08-24, filed 2 days after the tradedirector Yeung Danny Sheng Wu — Purchase on 2026-08-24, filed same daydirector Yeung Danny Sheng Wu — Purchase on 2026-08-24, filed same daydirector Yeung Danny Sheng Wu — Purchase on 2026-08-20, filed 4 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-25Rosin Brian JofficerPurchase5,100 @ $22.80$116K+28.3% of holdingnot yet — horizon still opennot yet — horizon still open23,100Form 4 · filed 1 day after the trade
2026-08-24Rosin Brian JofficerPurchase18,000 @ $21.19$381Kownership Δ n/anot yet — horizon still opennot yet — horizon still open18,000Form 4 · filed 2 days after the trade
2026-08-24Yeung Danny Sheng WudirectorPurchase11,181 @ $21.40$239K+11.0% of holdingnot yet — horizon still opennot yet — horizon still open112,416Form 4 · filed same day
2026-08-24Yeung Danny Sheng WudirectorPurchase6,000 @ $20.90$125K+6.3% of holdingnot yet — horizon still opennot yet — horizon still open101,235Form 4 · filed same day
2026-08-20Yeung Danny Sheng WudirectorPurchase7,500 @ $18.31$137K+8.5% of holdingnot yet — horizon still opennot yet — horizon still open95,235Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

20 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-04Leogrande Hudson BlakedirectorOption exercise2,0006,001Form 4
2026-09-04Leogrande Hudson BlakedirectorOption exercise2,00018,003Form 4
2026-09-03Tat Thuan YenofficerAward / grant10,73010,730Form 4
2026-08-21Lo Hoi ChunofficerOption exercise491,02961,086Form 4
2026-08-21Lo Hoi ChunofficerOption exercise32,736566,013Form 4
2026-08-21Lo Hoi ChunofficerOption exercise45,81561,086Form 4
2026-08-21Lo Hoi ChunofficerOption exercise45,815566,013Form 4
2026-08-20Yeung Danny Sheng WudirectorOption exercise809,2950Form 4
2026-08-20Yeung Danny Sheng WudirectorOption exercise53,953137,647Form 4
2026-08-20Yeung Danny Sheng WudirectorOther acquisition49,91287,735Form 4
2026-08-04Leogrande Hudson BlakedirectorOption exercise2,0014,001Form 4
2026-08-04Leogrande Hudson BlakedirectorOption exercise2,00120,003Form 4
2026-07-04Leogrande Hudson BlakedirectorOption exercise2,00022,004Form 4
2026-07-04Leogrande Hudson BlakedirectorOption exercise2,0002,000Form 4
2026-06-15VANDERVEEN DAVIDdirectorOption exercise8,6810Form 4
2026-06-15VANDERVEEN DAVIDdirectorOption exercise6,94445,249Form 4
2026-06-15Cheng Yin PandirectorOption exercise15,8736,406Form 4
2026-06-15Cheng Yin PandirectorOption exercise15,87359,051Form 4
2026-05-26Cheng Yin PandirectorAward / grant6,40622,279Form 4
2026-05-19Lo Hoi ChunofficerAward / grant91,629597,930Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.